Post by
canadafan on Mar 18, 2024 12:34am
Yet another new week…
Oncolytics biotech has been though multiple weeks of relative silence.
The Q4 update was focused mostly on expanding production.
Thst imho is a huge signal of an expected positive future.
Not sure why thst is getting next to zero focus.
For those who are sharholders. I wish everyone a prosperous few weeks.
With funding into 2025, it is quite possible for mangement to move forward & await for the bracelet trial overall survival numbers.
An Intersting paradox!
The O.S. Numbers are based on survival of the patients.
obviously a number of which have not passed away yet.
That is great news for them & the trial.
Yet withiut the events ,the stats can not be indentified.
I would think that once certian timelines have beensurpassed. That general " event" can be discussed.
Something, I can look into.
anyine know of such dates?
again a paradox. The longer things wait, the closer to registration & the more valuable.
Yet, seeing " no activity" the SP drops.
A lot o& people will be saying " would, have , could have should have"
great Week all
stay safe & stay healthy.
i lost another friend to Cancer last week.
Comment by
Snowdrift on Mar 18, 2024 9:19am
Sorry for your loss, Canadafan.
Comment by
Buckhenry on Mar 18, 2024 2:28pm
The shelf life of pela is at least 25 years.
Comment by
CMHarring218431 on Mar 18, 2024 2:37pm
Really? More than you, perhaps!